Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

Background Critical examination of the quality and validity of available allergic rhinitis (AR)
literature is necessary to improve understanding and to appropriately translate this …

This comprehensive practice parameter for allergic rhinitis (AR) and nonallergic rhinitis
(NAR) provides updated guidance on diagnosis, assessment, selection of monotherapy and …

Backround Visual analogue scales (VAS) are psychometric measuring instruments
designed to document the characteristics of disease-related symptom severity in individual …

Objective Allergic rhinitis (AR) is one of the most common diseases affecting adults. It is the
most common chronic disease in children in the United States today and the fifth most …

Abstract The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a
World Health Organization workshop in 1999. The initial goals were (1) to propose a new …

Several unmet needs have been identified in allergic rhinitis: identification of the time of
onset of the pollen season, optimal control of rhinitis and comorbidities, patient stratification …

Allergic rhinitis (AR) poses a global health problem and can be challenging to treat. Many of
the current symptomatic treatments for AR have been available for decades, yet there has …

Allergic rhinitis affects 60 million of the US population, 1.4 billion of the global population,
and its prevalence appears to be increasing. The duration and severity of allergic rhinitis …

Background: Loratadine and montelukast are clinical first-line drugs in the treatment of
allergic rhinitis (AR). However, there is no clear evidence of the efficacy of loratadine …